Gynaecological sampling requires you to book an appointment. The treating physician is always responsible for interpreting your results.

Name and abbreviation of test: CERVICAL SCREENING Pt-Papa-1

Cervical Pap smear is used to detect malignant cervical cell changes and their precursors. It can also be used to assess inflammations such as yeast, trichomoniasis and bacterial flora, but the Pap smear sample cannot be used to detect sexually transmitted diseases, such as chlamydia.

Name and abbreviation of test: HUMAN PAPILLOMA VIRUS (HPV), NUCLEIC ACID (qualitative) -HPVNhO

Human papilloma virus (HPV) is the most significant factor in the development of malignant cervical cell changes. HPV infection will usually heal on its own, but may sometimes be prolonged and lead to an increased risk of precancerous changes. A negative HPV test result predicts a very low risk of malignant cell changes in the next few years. A positive test result should be discussed with a physician.

• The prerequisite for a reliable cytological diagnosis is a carefully collected and sufficiently large sample.
• The samples are collected by gynaecologists and Fimlab’s sample collectors.
• The samples are collected from cervix with dedicated tools.
• Your menstrual cycle, previous cell changes and other relevant background information will be recorded to your referral.

The screening method for cervical cancer also requires gynaecological sampling. Learn more about screening for cervical cancer.

You can read the preparation instruction for gynaecological sampling here.